Clinical Trial Update: Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TJO-083 in dry eye disease across Phase 1 and Phase 2 to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• TJO-083

Snippet

Sponsor: Taejoon Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 1, Phase 2 | Status: UNKNOWN